Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA
Clinical trial NCT05181735 · RECRUITING
Trial details
- NCT number
- NCT05181735
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2028-12-19
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.